Skip to content

Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients

Periodontal Status in Kidney Transplant Patients and the Effectiveness of Adjunctive Diode Laser Therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07532694
Acronym
KTRs
Enrollment
80
Registered
2026-04-16
Start date
2025-12-09
Completion date
2026-06-09
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant Recipients, Periodontitis

Keywords

diode laser, scaling and root planing, periodontal therapy, kidney transplantation, 16S rRNA, microbiome, C-reactive protein

Brief summary

This randomized controlled trial evaluates the efficacy of diode laser-assisted non-surgical periodontal therapy in kidney transplant recipients with periodontitis. Eighty participants will be allocated to two parallel groups: scaling and root planing (SRP) with adjunctive diode laser therapy or SRP alone. Clinical periodontal parameters, blood biomarkers, radiographic findings, and subgingival microbiome profiles will be assessed at baseline and during follow-up. The study aims to determine whether adjunctive diode laser therapy provides superior clinical and biological improvement compared with SRP alone.

Detailed description

* This is a prospective, parallel-group, randomized controlled clinical trial in kidney transplant recipients diagnosed with periodontitis. * Participants will be randomized in a 1:1 ratio to receive either SRP with adjunctive diode laser therapy (intervention arm) or SRP alone (control arm). * Follow-up visits are scheduled at baseline, 1 month, 3 months, and 6 months after treatment. * Main clinical outcomes include clinical attachment level (CAL), probing pocket depth (PPD), plaque-related indices, gingival inflammation (GI), bleeding on probing (BOP), and oral hygiene status (OHI-S). * Systemic laboratory outcomes include platelet count, urea, creatinine, and C-reactive protein (CRP). * Subgingival plaque samples will undergo next-generation sequencing of 16S ribosomal RNA (16S rRNA) at baseline and 1 month after treatment to evaluate microbiome changes. * Alveolar bone changes will be assessed radiographically according to the study imaging protocol.

Interventions

PROCEDUREScaling and Root Planing

Conventional non-surgical periodontal therapy performed according to the study protocol in both groups.

DEVICEDiode Laser

Adjunctive diode laser application to periodontal pockets after SRP in the experimental arm. Device specifications, wavelength, power settings, mode, fiber size, number of applications, and treatment sessions should match the approved protocol exactly.

Sponsors

Military Hospital 103
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Single or double masking only if the protocol truly supports it; otherwise choose None (Open Label). Recommended: Outcomes Assessor masked, if examiner blinding is feasible.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Kidney transplant recipients aged 18 years or older. * Diagnosis of periodontitis according to the study case definition. * Medically stable and able to undergo non-surgical periodontal treatment. * Willing and able to provide written informed consent and attend follow-up visits.

Exclusion criteria

* \- Periodontal treatment or systemic antibiotic use within the predefined exclusion window in the protocol. * Acute oral infection requiring urgent treatment. * Pregnancy or lactation, if excluded by the approved protocol. * Serious systemic condition or clinical instability judged by investigators to preclude study participation. * Inability to comply with study procedures or follow-up schedule.

Design outcomes

Primary

MeasureTime frameDescription
Change in clinical attachment level (CAL)Baseline, 1 month, 3 months, and 6 monthsMean change in CAL, measured in millimeters.
Change in probing pocket depth (PPD)Baseline, 1 month, 3 months, and 6 monthsMean change in CAL, measured in millimeters.

Secondary

MeasureTime frameDescription
Change in bleeding on probing (BOP)Baseline, 1 month, 3 months, and 6 monthsPercentage of sites with BOP.
Change in gingival index (GI)Baseline, 1 month, 3 months, and 6 monthsMean GI score
Change in plaque index (PlI)Baseline, 1 month, 3 months, and 6 monthsMean plaque index score.
Change in OHI-SBaseline, 1 month, 3 months, and 6 monthsMean simplified oral hygiene index score.
Change in platelet countBaseline, 1 month, 3 months, and 6 monthsPlatelet count from peripheral blood test.
Change in C-reactive protein (CRP)Baseline, 1 month, 3 months, and 6 monthsCRP concentration.
Change in subgingival microbiome composition by 16S rRNA sequencingBaseline and 1 monthRelative abundance and diversity metrics of subgingival microbiota.
Radiographic change in alveolar bone statusBaseline and 6 monthsRadiographic change in alveolar bone status assessed according to the study imaging protocol

Countries

Vietnam

Contacts

CONTACTThang V Dinh, Principal Investigator
bsdinhthang277@gmail.com+84971349066

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026